A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00210691 · COMPLETED
Trial details
- NCT number
- NCT00210691
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.